0000899243-19-023467.txt : 20190912
0000899243-19-023467.hdr.sgml : 20190912
20190912173520
ACCESSION NUMBER: 0000899243-19-023467
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190912
DATE AS OF CHANGE: 20190912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hecht Beth
CENTRAL INDEX KEY: 0001652410
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38536
FILM NUMBER: 191091115
MAIL ADDRESS:
STREET 1: C/O NEOS THERAPEUTICS, INC.
STREET 2: 2940 N. HIGHWAY 360
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001346302
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203352427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: STE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
BUSINESS PHONE: 512-498-2670
MAIL ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: STE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-07-01
2019-07-03
0
0001346302
XERIS PHARMACEUTICALS INC
XERS
0001652410
Hecht Beth
C/O XERIS PHARMACEUTICALS, INC.
180 N. LASALLE STREET, SUITE 1600
CHICAGO
IL
60601
0
1
0
0
See Remarks
Common Stock
3624
D
On July 3, 2019, the reporting person filed a Form 4 which inadvertently reported that, following her purchase of the underlying stock, she directly owned 3,928 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 3,624 shares of common stock.
Senior Vice President, General Counsel and Corporate Secretary
/s/ Beth Hecht
2019-09-12